All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a healthcare professional.
The PsOPsA Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy
Introducing
Now you can personalise
your PsOPsA Hub experience!
Bookmark content to read later
Select your specific areas of interest
View content recommended for you
Find out moreThe PsOPsA Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the PsOPsA Hub cannot guarantee the accuracy of translated content. The PsOPsA Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The PsOPsA Hub is supported by educational grants. All educational content is developed independently by SES in collaboration with our expert steering committee, with no input or influence from financial supporters. We would like to express our gratitude to the following companies for their support: • UCB: For website development, launch, and ongoing maintenance. • UCB and Bristol Myers Squibb: For educational content and news updates.
Paolo GisondiSteering Committee Chair
Paolo Gisondi is Associate Professor of Dermatology and Venereology and President of the Residence Program of the School of Specialization in Dermatology and Venereology at the University Hospital of Verona, Verona, IT.
Gisondi is an executive committee member of the European Academy of Dermatology and Venereology (EADV) and board representative for Italy (until September 9, 2022), a member of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), and a member of EULAR task force on the “EULAR Points to Consider for the definition of clinical and imaging features suspicious for progression to psoriatic arthritis”.
Gisondi’s main interests include the epidemiological, clinical, and therapeutic aspects of chronic plaque psoriasis and psoriatic arthritis. Apart from clinical research, more than half of his working hours are dedicated to the outpatient clinic, including dermatological basic surgery.